Similar articles

• [Hepatic encephalopathy: long-term therapy with neomycin is problematic].

  Held C, Briedigkeit H. Held C, et al. Z Arztl Fortbild (Jena). 1992 Apr 27;86(7-8):367-70. Z Arztl Fortbild (Jena). 1992. PMID: 1615717 German. No abstract available.
• [Use of neomycin in the treatment of acute hepatoportal encephalopathy].

  Gubskiĭ LV, Ershov IuA. Gubskiĭ LV, et al. Klin Med (Mosk). 1976 Apr;54(4):110-5. Klin Med (Mosk). 1976. PMID: 1016352 Russian. No abstract available.
• Urease and deaminase activities of fecal bacteria in hepatic coma.

  Sabbaj J, Sutter VL, Finegold SM. Sabbaj J, et al. Antimicrob Agents Chemother (Bethesda). 1970;10:181-5. Antimicrob Agents Chemother (Bethesda). 1970. PMID: 5521334 No abstract available.
• [Exogenous hepatic coma--standard therapy with amino acid solutions].

  Bode JC, Reiter HJ. Bode JC, et al. Beitr Infusionther Klin Ernahr. 1979;(4):49-62. Beitr Infusionther Klin Ernahr. 1979. PMID: 399584 Review. German. No abstract available.
• New approaches in the management of fulminant hepatic failure.

  Krone CL. Krone CL. Ariz Med. 1971 Apr;28(4):284-7. Ariz Med. 1971. PMID: 4930377 Review. No abstract available.